Early-Onset Cerebral Amyloid Angiopathy and Alzheimer Disease Related to an APP Locus Triplication
Authors:
- Lou GrangeonLGLou Grangeon
- Kévin CassinariKCKévin Cassinari
- Stéphane RousseauSRStéphane Rousseau
- Bernard CroisileBCBernard Croisile
- Maïté FormaglioMFMaïté Formaglio
- Olivier MoreaudOMOlivier Moreaud
- Jean BoutonnatJBJean Boutonnat
- Nathalie Le MeurNMNathalie Le Meur
- Manuele MinéMMManuele Miné
- Thibault CosteTCThibault Coste
- Eva PipirasEPEva Pipiras
- Elisabeth Tournier-LasserveETElisabeth Tournier-Lasserve
Open Access
- 8 September 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology Genetics
- Vol. 7 (5) , e609
Abstract
Background and Objective To report a triplication of the amyloid-β precursor protein (APP) locus along with relative messenger RNA (mRNA) expression in a family with autosomal dominant early-onset cerebral amyloid angiopathy (CAA) and Alzheimer disease (AD). Methods Four copies of the APP gene were identified by quantitative multiplex PCR of short fluorescent fragments, fluorescent in situ hybridization (FISH), and array comparative genomic hybridization. APP mRNA levels were assessed using reverse-transcription–digital droplet PCR in the proband9s whole blood and compared with 10 controls and 9 APP duplication carriers. Results Beginning at age 39 years, the proband developed severe episodic memory deficits with a CSF biomarker profile typical of AD and multiple lobar microbleeds in the posterior regions on brain MRI. His father had seizures and recurrent cerebral hemorrhage since the age of 37 years. His cerebral biopsy showed abundant perivascular amyloid deposits, leading to a diagnosis of CAA. In the proband, we identified 4 copies of a 506-kb region located on chromosome 21q21.3 and encompassing the whole APP gene without any other gene. FISH suggested that the genotype of the proband was 3 copies/1 copy corresponding to an APP locus triplication, which was consistent with the presence of 2 APP copies in the healthy mother and with the paternal medical history. Analysis of the APP mRNA level showed a 2-fold increase in the proband and a 1.8 fold increase in APP duplication carriers compared with controls. Discussion Increased copy number of APP is sufficient to cause AD and CAA, with likely earlier onset in case of triplication compared with duplication.Keywords
This publication has 12 references indexed in Scilit:
- Genetic fine-mapping of the Iowan SNCA gene triplication in a patient with Parkinson’s diseasenpj Parkinson's Disease, 2018
- Patterns and severity of vascular amyloid in Alzheimer’s disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer’s diseaseActa Neuropathologica, 2018
- APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic casesPLOS Medicine, 2017
- Seizures in dominantly inherited Alzheimer diseaseNeurology, 2016
- The French Series of Autosomal Dominant Early Onset Alzheimer's Disease Cases: Mutation Spectrum and Cerebrospinal Fluid BiomarkersJournal of Alzheimer’s Disease, 2012
- Amyloid-β Protein Precursor Gene Expression in Alzheimer's Disease and Other ConditionsJournal of Alzheimer’s Disease, 2012
- The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- INTRAFAMILIAL DIVERSITY OF PHENOTYPE ASSOCIATED WITH APP DUPLICATIONNeurology, 2008
- APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathyBrain, 2006
- APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathyNature Genetics, 2005